Back to 
BNP PARIBAS FINANCIAL MARKETS
BNP PARIBAS FINANCIAL MARKETS
KNSA
Showing 0 of 23 quarters
Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in KINIKSA PHARMACEUTICALS-A
As of its Q1 2024 13F, BNP Paribas Financial Markets held 46,060 shares of KNSA (Kiniksa Pharmaceuticals), worth $908,764. BNP Paribas Financial Markets' 13F filings listed KNSA from Q4 2018 to Q1 2024, 22 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.